ArticleDrug development and industrial pharmacy2014

Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.